ArticleDiagnostic pathology2026
A novel multimodal framework integrating pathomics, deep learning, and machine learning for breast cancer histological grades classification.
Article in Diagnostic pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe present study is aimed at developing and testing a strong, interpretable, and multi-scale computational pathology framework for the automated histologic grade (grade-based) grading of invasive ductal carcinoma (IDC) from hematoxylin and eosin (H&E) whole-slide images (WSIs). MATERIALS AND
methodsA multi-center dataset consisting of 3,660 WSIs from 925 patients with IDC from five institutions was assembled and quality controls were very stringent. Images were captured at four magnifications (4X, 10X, 20X, 40X), in order to capture both a view of global tissue architecture and fine detail of the nuclei. Multi-modality features were extracted: low and high magnification deep features (DINOv2 ViT-S/16, ConvNeXt V2 Small), 71 handcrafted radiomics descriptors extracted from H&E channels and three pseudo-nuclei indices. Correlation filtering and four feature selection approaches (mutual information, recursive feature elimination, ANOVA, LASSO) were used on a modality per modality basis. An Attention MIL framework with a novel cross scale attention module and cross scale consistency loss was used for feature fusion and grading. Three strategies of fusion (early, late, hybrid) were compared. Model performance was evaluated using 5-folder cross-validation, internal, and external validation on an independent cohort (n = 922 WSIs).
resultsThe hybrid fusion of LASSO selected features resulted in the best performance as the accuracy was found to be 92.5% (internal) and 90.9% (external) and the AUC were found to be 93.5% and 92.1% respectively. High magnitude deep features proved to be the most informative single modality and multi-modality fusion increased both the accuracy and robustness. The proposed framework was better than end-to-end baselines (p < 0.001), and the recall was balanced across all grades. Attention heatmaps identified regions of diagnostic interest which were consistent with pathologist annotations.
conclusionsThe multi-scaled, multi modal Attention-MIL framework provides accurate, interpretable and generalizable grading of IDC, outperforming conventional and end-to-end methods. Its inter-institutional strength and biological interpretability make it an appealing candidate for a clinical decision-support tool.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.